SanBio’s World-Leading Team for Regenerative Cell Medicine Development
SanBio initially brought on board Professor Hideyuki Okano (current Dean, Keio University School of Medicine), one of the world’s leading authorities in regenerative medicine, as the founding scientist of our company. Dr. Okano has worked with the company on the rapidly-growing body of science in this field since the Company’s inception.
More recently SanBio was joined by Damien Bates, M.D., Ph.D, who previously led the effort which achieved the first FDA approval for the use of an allogeneic cell based product, and Michael McGrogan, PhD, who led the world's first scaled-up production of regenerative cell medicines, to head its R&D department and manufacturing department, respectively. From research through clinical testing and commercial scale production, we believe SanBio has the world’s top team in regenerative medicine.
With its world-recognized team, SanBio leads the field of regenerative cell medicine development.
( as of September 30, 2017 )